9.30am - 10.00am Registration and morning coffee

10.00am - 10.10am

Welcome and Official Opening
Glenn Cross, Chief Executive Officer, AusBiotech

10.10am - 10.30am

KEYNOTE: Pharma 2030 - opportunities for biotech companies, business models and trends

Jia Zhou
, Director, Global Strategy Group, KPMG Hong Kong
- presentation slides not available for distribution


10.30am - 11.15am

Company Spotlight Presentations

- Dr Brad Walsh, Chief Executive Officer, Minomic International
-link to presentation

- Dr Ross Macdonald, Managing Director and Chief Executive Officer, Cynata Therapeutics Limited (ASX:CYP)
- link to presentation

11.15am - 11.45am Morning tea and networking opportunity

11.45am - 12.15pm

KEYNOTE: Australian Life Science companies raising capital and forming partnerships in the Greater China Region

Mr Rani Jarkas, Chairman, Cedrus Investments Hong Kong
- link to presentation

12.15pm - 1.00pm

Company Spotlight Presentations

John Martin, Chief Executive Officer, Regeneus (ASX:RGS)
- link to presentation

Steven Lydeamore, Chief Financial Officer, Bionomics Limited (ASX:BNO)
- link to presentation - English version / Chinese version

- Robert Proulx, Chief Executive Officer, Imagion Biosystems (ASX:IBX)
- link to presentation

- Assoc Professor Derek Richard, CARP Pharmaceuticals
- link to presentation

1.00pm - 2.00pm

Lunch and networking opportunity

2.00pm - 2.30pm

Company Spotlight Presentations

- Dr Ryan Parlett, Director Business Management Pharma Services, Patheon
- link to presentation

Megan Ford, Senior Director Research & Development, IQVIA
- link to presentation

- Rob Scott, Director, ChinaBlueSky Partners on for Australia China Technology Incubator - link to presentation

2.30pm - 2.45pm

KEYNOTE: Australian healthcare investment environment and support from Austrade

Sam Guthrie, Senior Trade Commissioner, Australian Trade and Investment Commission
- link to presentation

2.45pm - 3.00pm

PRESENTATION: The growth opportunity for life sciences in Australia

Glenn Cross, Chief Executive Officer, AusBiotech

PRESENTATION: Clinical Trials in Australia

Sue MacLeman, Managing Director and Chief Executive Officer, MTPConnect (MedTech and Pharma Growth Centre-MTP-IIGC Ltd), Australia
- link to presentation English version / Chinese version

3.00pm - 4.30pm

Networking Reception

Venue: KPMG Hong Kong